Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2017-000368-14-SE
EUCTR2017-000368-14-SE
Active, not recruiting
Phase 1

A head-to-head randomized clinical trial of methylphenidate and lisdexamphetamine treatment for executive functions and global functioning in adults with ADHD - A clinical trial with two psychostimulants of Central Nervous System in adults with ADHD

Sahlgrenska Univerisity Hospital Gothenburg0 sites120 target enrollmentMarch 30, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsElvanseConcerta

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Sahlgrenska Univerisity Hospital Gothenburg
Enrollment
120
Status
Active, not recruiting
Last Updated
7 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 30, 2017
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Sahlgrenska Univerisity Hospital Gothenburg

Eligibility Criteria

Inclusion Criteria

  • •Adults 18\-45 years of age
  • •Clinical diagnosis ADHD of any subtype and DSM 5 presentation
  • •Intellectual ability in the normal range, according to clinical judgment
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 120
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Physical or mental limitations that make cognitive evaluations unsuitable.
  • •Cardiovascular disease, seizures or other unstable medical conditions that might increase the risk for the subject.
  • •Bipolar Disorder, Conduct Disorder, Psychosis, severe autism or other severe comorbid or medical conditions that in the investigator's opinion would make study participation unsuitable.
  • •Substance abuse.
  • •Subjects who has previously been treated with ADHD medication.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
Metformin and Body Mass Index of Patients under Treatment with SSRICondition 1: Obesity. Condition 2: Depression. Condition 3: Anxiety Disorders.Drug-induced obesityMajor depressive disorder, single episode, severe without psychotic featuresOther anxiety disordersE66.1F32.2
IRCT20140102016035N3Rasht University of Medical Sciences60
Not yet recruiting
Phase 2
The effectiveness of wires for lingual fixed retainers after orthodontic treatment
IRCT20230602058366N1Birjand University of Medical Sciences170
Not yet recruiting
Phase 2
The maxillary first molar distalization in orthodontic patient
IRCT20200509047357N1Mashhad University of Medical Sciences30
Recruiting
Phase 2
The effectiveness of mouthwash that contains amorphous calcium phosphate nanoparticles in a chitosan therapy on tooth decay.
IRCT20190821044572N1Mashhad University of Medical Sciences45
Not yet recruiting
Not Applicable
Maxillary molar distalization in patients who need orthodontic treatment
IRCT20170128032230N2Mashhad University of Medical Sciences30